Tweet
An assay that I have run on the miniseq previously is starting to give me problems and I am at a loss on what it could be. My problem on the surface looks like underloading. My cluster density is around 124 k/mm2 and phiX is around 2.5%. However, I ran an old library the previously gave me good numbers (i.e. 240K/mm2, 1% phix) has dropped to the poor numbers I first mentioned. I swapped out lots of the flow cell and the results recovered. However, the following day the numbers dropped again and even worse on the third day. My cluster density decreased from 240 to 174 to 109 k/mm2. I looked at the image of the clusters and looks heavily clustered and does not look like 109 k/mm2. The other metrics like pass filter and Q30 etc are fantastic, above 95%. The problem is that I lose depth at all of my targeted amplicons as a result of the underclustering. I tried new NaOH and TrisHCl to no avail. It seems that my library is somehow binding less efficiently and phix isnt as affected. On a side note, I have noticed some bubbles in the flow cell but I am not sure if this is normal and introduced during the post run wash cycle. Any ideas will be helpful! Thanks!
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment